Reactive carbonyl species (RCS) (RCS)

Reactive carbonyl species (RCS), including alpha,beta-dicarbonyls like methylglyoxal and glyoxal, are highly reactive metabolic byproducts that play a central role in "carbonyl stress." These molecules are primarily generated through the degradation of glycolytic intermediates and lipid peroxidation. RCS are potent precursors for the formation of Advanced Glycation End-products (AGEs), which occur through the non-enzymatic modification of proteins, lipids, and nucleic acids. This process, known as the Maillard reaction, leads to the formation of irreversible cross-links that impair the structural integrity and biological function of long-lived proteins such as collagen. Pathologically, the accumulation of RCS and subsequent AGE adduct formation are strongly linked to the development of diabetic complications, chronic kidney disease, and neurodegenerative disorders like Alzheimer's disease (Schalkwijk & Stehouwer, 2020, Physiological Reviews). Therapeutic interventions targeting this pathway typically involve "carbonyl scavengers"—small molecules designed to chemically neutralize RCS before they can react with endogenous targets (Rabbani & Thornalley, 2015, Biochemical Society Transactions). While several candidates like aminoguanidine and pyridoxamine have reached clinical trials, success has been limited by safety concerns, including off-target reactivity with essential physiological carbonyls like Vitamin B6.

Other names

Alpha,beta-dicarbonylsDicarbonyl stressAGE precursorsMethylglyoxal (MG)Glyoxal (GO)3-Deoxyglucosone (3-DG)Reactive dicarbonyls

Carbonyl scavenging (direct chemical neutralization of dicarbonyls), inhibition of the Maillard reaction, and reduction of AGE precursor formation.